Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAB4A antisense RNA 1 (RAB4A-AS1) is a long non-coding RNA transcribed antisense to the RAB4A gene, which encodes a member of the Ras superfamily of small GTPases involved in membrane trafficking[1]. Antisense RNAs, including RAB4A-AS1 by analogy, are important post-transcriptional regulators that can modulate gene expression in cis or trans via interference with their sense counterparts, affecting processes such as transcription, RNA stability, and chromatin remodeling[3]. While antisense lncRNAs can be involved in crucial regulatory mechanisms, specific functional roles, disease associations, or pharmacological interventions for RAB4A-AS1 have not been directly characterized in available literature[1][2][4][5]. Most biological and pharmacological data available pertain to the protein-coding RAB4A gene, not its antisense transcript. Essential context: - Available search results do not support RAB4A-AS1 as a current therapeutic target, nor do they provide functional or disease-specific data pertaining directly to this antisense transcript. - The bulk of search results and therapeutic relevance concern the RAB4A protein, not RAB4A-AS1[1][2][4][5]. - Regulatory antisense RNAs as a class are increasingly studied, but individual characterization for RAB4A-AS1 is lacking[3]. Summary for structured data: RAB4A-AS1 is a long non-coding, antisense RNA related to the RAB4A gene, with putative functions in gene expression regulation. It is not a classical molecular target, does not have documented interacting drugs or mechanisms, and requires further research for therapeutic and diagnostic relevance. The provided name and abbreviation are accurate, but this transcript is not currently a focus for drug development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAB4A antisense RNA 1 (RAB4A-AS1).